Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Michael Harrison
- Study ID
- NCT02431507
- Status
- Recruiting
Conditions
- Obstructive Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Magnap — DEVICEThis is a non-randomized clinical trial.Patients 21-70 years diagnosed with moderate to severe obstructive sleep apnea will have the Magnap Magnetic Apnea Device surgically implanted on the subject's hyoid bone and used in conjunction with an external neck brace and magnet to open airway during sleep in treatment of Obstructive Sleep Apnea. We will monitor for safety, brace compliance and improvement of symptoms of sleep apnea for a total of 13 months.
Study Details
The purpose of this study is to determine the safety and feasibility of the Magnap magnetic device in the treatment of obstructive sleep apnea (OSA).
Key Dates
- Start date
- Sep 30, 2015
- Status verified
- Dec 2025
- Primary completion
- Dec 1, 2026
- Completion
- Mar 1, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment Arm with Magnetic Apnea DeviceThe treatment arm with magnetic apnea device includes: surgical implantation of the magnetic apnea device(MAGNAP) to treat obstructive sleep apnea in each eligible enrolled subject . A custom fitted external brace will be created for wear throughout the 13 months of treatment and evaluated for improvement of symptoms..
Primary Outcome Measure
Ability of the subject to use the Magnap device for the duration of the study. [ Time Frame: 13 months ]
Central Contacts
- Jeff Jensen, BS415-640-5245
- Michael Danty, MS7074848774
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco/Mount Zion Hospital | San Francisco | California | 94115 | Jolie Chang, MD (SUB_INVESTIGATOR) Andrew Murr, MD (SUB_INVESTIGATOR) David Claman, MD (SUB_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Do Endotypes Predict Response and Sequelae in OSA PatientsPHASE2 · Recruiting · University of California, San Diego · La Jolla, California
- OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment UnitRecruiting · VA Office of Research and Development · San Diego, California
- The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)PHASE2 · Recruiting · University of California, San Diego · La Jolla, California
- Enhancing PAP Adherence Among Spanish-speaking Hispanic Adults With OSANot Yet Recruiting · Geisinger Clinic · Fontana, California